Jiabing Zhou

No ORCID on file · 1 paper in corpus
lab-animal 2013
Journal of ovarian research ·doi:10.1186/1757-2215-6-80

BACKGROUND: RNA interference technology has shown high therapeutic potential for cancer treatment. However, serum instability, poor tissue permeability and non-specific uptake of short interfering RNA (siRNA) limit its administration in viv…